Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Assets (2016 - 2026)

Tenax Therapeutics' Assets history spans 6 years, with the latest figure at $9.9 million for Q4 2017.

  • On a quarterly basis, Assets fell 57.62% to $9.9 million in Q4 2017 year-over-year; TTM through Dec 2017 was $9.9 million, a 57.62% decrease, with the full-year FY2017 number at $9.9 million, down 57.62% from a year prior.
  • Assets hit $9.9 million in Q4 2017 for Tenax Therapeutics, down from $11.0 million in the prior quarter.
  • Over the last five years, Assets for TENX hit a ceiling of $73.0 million in Q4 2015 and a floor of $3.0 million in Q1 2013.
  • Historically, Assets has averaged $28.0 million across 4 years, with a median of $16.3 million in 2017.
  • Biggest five-year swings in Assets: fell 23.21% in 2013 and later plummeted 81.57% in 2017.
  • Tracing TENX's Assets over 4 years: stood at $3.2 million in 2013, then soared by 2194.73% to $73.0 million in 2015, then tumbled by 68.02% to $23.3 million in 2016, then tumbled by 57.62% to $9.9 million in 2017.
  • Business Quant data shows Assets for TENX at $9.9 million in Q4 2017, $11.0 million in Q3 2017, and $13.4 million in Q2 2017.